loadpatents
name:-0.025505781173706
name:-0.012846946716309
name:-0.0031569004058838
Pierra; Claire Patent Filings

Pierra; Claire

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pierra; Claire.The latest application filed is for "d-amino acid compounds for liver disease".

Company Profile
2.18.27
  • Pierra; Claire - Montarnaud FR
  • Pierra; Claire - Montramaud FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
2'-chloro nucleoside analogs for HCV infection
Grant 10,513,534 - Gosselin , et al. Dec
2019-12-24
D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
Grant 10,238,680 - Mayes , et al.
2019-03-26
D-amino Acid Compounds For Liver Disease
App 20180258130 - MAYES; Benjamin Alexander ;   et al.
2018-09-13
2'-dichloro And 2'-fluoro-2'-chloro Nucleoside Analogues For Hcv Infection
App 20170198005 - Paparin; Jean-Laurent ;   et al.
2017-07-13
Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections
Grant 9,403,863 - Surleraux , et al. August 2, 2
2016-08-02
3'-deoxy nucleosides for the treatment of HCV
Grant 9,309,275 - Stewart , et al. April 12, 2
2016-04-12
D-amino Acid Phosphoramidate Pronucleotides Of Halogeno Pyrimidine Compounds For Liver Disease
App 20160082030 - Mayes; Benjamin Alexander ;   et al.
2016-03-24
2'-chloro Nucleoside Analogs For Hcv Infection
App 20160083413 - Gosselin; Gilles ;   et al.
2016-03-24
Compounds and pharmaceutical compositions for the treatment of viral infections
Grant 9,249,173 - Sommadossi , et al. February 2, 2
2016-02-02
D-amino Acid Compounds For Liver Disease
App 20160002281 - MAYES; Benjamin Alexander ;   et al.
2016-01-07
5,5-fused arylene or heteroarylene hepatitis C virus inhibitors
Grant 9,187,496 - Dousson , et al. November 17, 2
2015-11-17
3',5'-cyclic phosphoramidate prodrugs for HCV infection
Grant 9,109,001 - Parsy , et al. August 18, 2
2015-08-18
Compounds and pharmaceutical compositions for the treatment of viral infections
Grant 8,951,985 - Surleraux , et al. February 10, 2
2015-02-10
D-amino Acid Phosphoramidate Pronucleotides Of Halogeno Pyrimidine Compounds For Liver Disease
App 20150037282 - MAYES; Benjamin Alexander ;   et al.
2015-02-05
Compounds And Pharmaceutical Compositions For The Treatment Of Viral Infections
App 20140255339 - SOMMADOSSI; Jean-Pierre ;   et al.
2014-09-11
3'-deoxy Nucleosides For The Treatment Of Hcv
App 20140248241 - STEWART; Alistair James ;   et al.
2014-09-04
2'-chloro Nucleoside Analogs For Hcv Infection
App 20140099283 - GOSSELIN; Gilles ;   et al.
2014-04-10
Compounds and pharmaceutical compositions for the treatment of viral infections
Grant 8,691,788 - Sommadossi , et al. April 8, 2
2014-04-08
3',5'-cyclic Phosphoramidate Prodrugs For Hcv Infection
App 20130315866 - PARSY; Christophe Claude ;   et al.
2013-11-28
5,5-fused Arylene Or Heteroarylene Hepatitis C Virus Inhibitors
App 20130071352 - Dousson; Cyril B. ;   et al.
2013-03-21
Compounds And Pharmaceutical Compositions For The Treatment Of Viral Infections
App 20130064793 - SURLERAUX; Dominique ;   et al.
2013-03-14
Substituted Carbonyloxymethylphosphoramidate Compounds and Pharmaceutical Compositions for the Treatment of Viral Infections
App 20130064794 - Surleraux; Dominique ;   et al.
2013-03-14
5,5-fused arylene or heteroarylene hepatitis C virus inhibitors
Grant 8,362,068 - Dousson , et al. January 29, 2
2013-01-29
Methods For Treating Drug-resistant Hepatitis C Virus Infection With A 5,5-fused Arylene Or Heteroarylene Hepatitis C Virus Inhibitor
App 20120252721 - Dousson; Cyril B. ;   et al.
2012-10-04
Phosphothiophene and phosphothiazole HCV polymerase inhibitors
Grant 8,193,372 - Dousson , et al. June 5, 2
2012-06-05
Compounds And Pharmaceutical Compositions For The Treatment Of Viral Infections
App 20110286962 - SOMMADOSSI; Jean-Pierre ;   et al.
2011-11-24
5,5-fused Arylene Or Heteroarylene Hepatitis C Virus Inhibitors
App 20110150827 - Dousson; Cyril B. ;   et al.
2011-06-23
Compounds and pharmaceutical compositions for the treatment of viral infections
Grant 7,951,789 - Sommadossi , et al. May 31, 2
2011-05-31
Phosphadiazine HCV polymerase inhibitors IV
Grant 7,932,240 - Dousson , et al. April 26, 2
2011-04-26
Compounds and pharmaceutical compositions for the treatment of viral infections
Grant 7,902,202 - Sommadossi , et al. March 8, 2
2011-03-08
Nucleosides With Non-Natural Bases as Anti-Viral Agents
App 20100279974 - Pierra; Claire ;   et al.
2010-11-04
Phosphothiophene And Phosphothiazole Hcv Polymerase Inhibitors
App 20100233123 - Dousson; Cyril ;   et al.
2010-09-16
Compounds and Pharmaceutical Compositions for the Treatment of Viral Infections
App 20090238790 - SOMMADOSSI; Jean-Pierre ;   et al.
2009-09-24
Compounds and Pharmaceutical compositions for the treatment of Viral infections
App 20090169504 - Sommadossi; Jean-Pierre ;   et al.
2009-07-02
Phosphadiazine Hcv Polymerase Inhibitors Iv
App 20090081158 - Dousson; Cyril ;   et al.
2009-03-26
Phosphadiazine Hcv Polymerase Inhibitors Iii And Vi
App 20090060867 - Dousson; Cyril ;   et al.
2009-03-05
Phosphadiazine Hcv Polymerase Inhibitors I And Ii
App 20090060866 - Dousson; Cyril ;   et al.
2009-03-05
Compounds and pharmaceutical compositions for the treatment of viral infections
App 20080286230 - Sommadossi; Jean-Pierre ;   et al.
2008-11-20
Compounds and pharmaceutical compositions for the treatment of liver disorders
App 20080261913 - Sommadossi; Jean-Pierre ;   et al.
2008-10-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed